CollPlant Biotechnologies... (CLGN)
NASDAQ: CLGN
· Real-Time Price · USD
1.38
-0.08 (-5.15%)
At close: Jun 26, 2025, 3:59 PM
1.45
5.45%
Pre-market: Jun 27, 2025, 07:31 AM EDT
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|
| Israel Revenue | 31K | 5K | 174K | 15.01M |
| Israel Revenue Growth | +520.00% | -97.13% | -98.84% | n/a |
| United States Revenue | 484K | 10.84M | n/a | n/a |
| United States Revenue Growth | -95.53% | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.41M | 1.32M | 1.41M | 1.42M | 1.2M | 1.2M | 1.67M | 1.32M | 1.52M | 2.04M | 1.54M | 1.61M | 1.56M | 1.38M | 1.18M | 1.42M | 1.96M | 1.55M | 1.05M | 986K | 1.03M | 1.16M | 653K | 944K | 870K | 857.36K | 750.71K | 845.77K | 981.03K | 1.18M | 356.97K | 455.6K | 370.1K | 1.26M | 480.76K | 561.99K | 538.28K | 2.73M | 419.94K | 378.6K | 281.54K |
| Selling, General, and Administrative Revenue Growth | +6.58% | -5.84% | -1.20% | +18.90% | -0.08% | -28.41% | +26.86% | -13.57% | -25.06% | +32.49% | -4.54% | +3.07% | +13.36% | +16.30% | -16.85% | -27.16% | +25.97% | +47.53% | +6.69% | -4.36% | -10.81% | +77.03% | -30.83% | +8.51% | +1.47% | +14.21% | -11.24% | -13.79% | -17.10% | +231.51% | -21.65% | +23.10% | -70.68% | +162.56% | -14.45% | +4.41% | -80.28% | +550.09% | +10.92% | +34.47% | n/a |
| Research and Development Revenue | 2.1M | 2.54M | 2.87M | 2.7M | 2.41M | 3.11M | 2.69M | 2.57M | 2.1M | 2.64M | 2.78M | 2.6M | 2.24M | 2.19M | 1.91M | 1.9M | 1.63M | 1.33M | 921K | 1M | 810K | 1.69M | 1.05M | 797K | 875K | 2.45M | 944.75K | 638.29K | 1.27M | 857.12K | 778.25K | 1.23M | 1.12M | 454.08K | 1.34M | 1.1M | 1.43M | 1.04M | 801.96K | 592.64K | 626.52K |
| Research and Development Revenue Growth | -17.22% | -11.36% | +6.38% | +12.09% | -22.71% | +15.51% | +4.70% | +22.45% | -20.29% | -5.04% | +6.85% | +15.92% | +2.42% | +14.73% | +0.37% | +16.41% | +22.60% | +44.63% | -8.08% | +23.70% | -52.04% | +60.40% | +32.12% | -8.91% | -64.28% | +159.27% | +48.01% | -49.82% | +48.41% | +10.13% | -36.85% | +10.47% | +145.67% | -66.13% | +21.82% | -23.00% | +37.95% | +29.21% | +35.32% | -5.41% | n/a |